A rare case report of diclofenac induced Steven Johnson syndrome
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20243044Keywords:
Steven Johnson syndrome, Diclofenac, Adverse drug reaction, PharmacovigilanceAbstract
Stevens Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) are acute life-threatening mucocutaneous diseases characterized by extensive necrosis involving the mucous membrane and epidermis. In this case, a 54-year-old female after intake of prescribed diclofenac tablet presented with multiple reddish maculopapular eruptions over face, abdomen, both limbs, over lips and oral cavity associated with pain and intense pruritus. This case is a rare presentation of drug induced SJS caused by commonly prescribed NSAID, diclofenac. Patient’s condition improved after withdrawal of offending drug and prompt treatment. This case suggests that emphasis on early detection, assessment and timely management of adverse drug reactions is of upmost importance. Thus, establishment of proper vigilance centre and regular monitoring is necessary and taking caution in prescribing drugs as well in elderly groups.
References
Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller AS, Leffell. D.Fitzpatrick’s Dermatology in General Medicine, 8th E. McGraw-Hill. 2011. Available at: https://www.scholars.northwestern.edu/en.
Hirapara HN, Patel TK, Barvaliya MJ, Tripathi C. Drug-induced Stevens-Johnson syndrome in Indian population: A multricentric retrospective analysis. Niger J Clin Pract. 2017;20:978-83.
Harr and French: Toxic epidermal necrolysis and Stevens-Johnson Syndrome. Orphanet J Rare Dis. 2010;5:39.
Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal anti-inflammatory drugs: A review of the literature. Am J Health-Syst Pharm. 2010;67:12-9.
Yang SC, Hu S, Zhang SS, Huang JW, Zhang J, Ji Chao, et al. The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China. J Immunol Res. 2018;43:205.
Kaniwa N, Saito Y, Aihara M, Matsunnaga K, Tohkin M, Kurose K, et al. HLA-B 1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilespsia. 2010;51:2461-5.
Gor AP, Saksena M. Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients. J Pharmacol Pharmacother. 2011;2(1):26-9.
Yaser Mohammad Al-Worafi, in Drug Safety in Developing Countries 2020, Adverse drug reactions. Available at: https://shop.elsevier.com/books.
Patel TK, Barvaliya MJ, Sharma D, Tripathi C. A systemic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population. Indian J Dermatol Venereol Leprol. 2013;79:389-98.
Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428(6982):486.
Ling YF, Yang CH. Severe cutaneous adverse reactions related to systemic antibiotics. Clini Infec Dis. 2014;58(10):1377-85.
Bendi SR, Suvvari TK. A case report of stevens Johnson syndrome and toxic epidermal necrolysis due to diclofenac sodium. Int J Basic Clin Pharmacol. 2020;9(7):1132-4.
Hawboldt J. Adverse Events Associated with NSAIDs. US Pharm. 2008;12:5-13.
Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715-31.
Wiwanitkit V. Diclofenac related skin rash, a case report.Thai J Pharmacol. 2002;24:2-3.
Babamahamoodi F, Eslami G, Babamahamoodi A. Diclofenac-Induced Stevens-Johnson Syndrome: A case report. Inter J Pharmacol Therap.2012.11(1)33-5.
Suenaga H. Diclofenac sodium induced Stevens-Johnson syndrome in a hospitalized patient during treatment of splenic injury and mandibular fracture. J Oral Maxillofac Surg Med Pathol. 2013;27(1):29-32.
Moitra S, Sukanta S, Banerjee I, Das P, Tripathi S. Diclofenac-Serratiopeptidase combination induced stevens-johnson syndrome- a rare case report with review of literature. J of Clin Diag Res. 2014;8(7):8-11.
Shetty SR, Chatra L, Prashanth S, Rao PK. Stevens-Johnson syndrome: a case report. J Oral Sci. 2010;52(2):343-6.
Frantz R, Huang S, Are Abhirup Motaparthi K. Stevens-Johnson syndrome and toxic necrolysis: a review of diagnosis and management. Medicina (Kaunas). 2021;57(9):895.
Magina S, Lisboa C, Leal V, Palmares J, Mesquita-Guimares J. Dermatological and opthalmological sequels in toxic epidermal necrolysis in children. Pediatrics. 2002;109:74-8.
Coleman JJ, Pontefract SK. Adverse drug reactions. Clinical Medicine 2016;16(5):481-5.